PT  - JOURNAL ARTICLE
AU  - Akito Tsukinaga
AU  - Shunsuke Takaki
AU  - Takahiro Mihara
AU  - Kenta Okamura
AU  - Susumu Isoda
AU  - Kiyoyasu Kurahashi
AU  - Takahisa Goto
TI  - Low hematocrit levels: a risk factor for long-term outcomes in patients requiring prolonged mechanical ventilation after cardiovascular surgery. A retrospective study
AID  - 10.1136/jim-2019-001122
DP  - 2020 Feb 01
TA  - Journal of Investigative Medicine
PG  - 392--396
VI  - 68
IP  - 2
4099  - http://hw-f5-jim.highwire.org/content/68/2/392.short
4100  - http://hw-f5-jim.highwire.org/content/68/2/392.full
SO  - J Investig Med2020 Feb 01; 68
AB  - While low-risk patients who undergo elective surgery can tolerate low hematocrit levels, the benefits of higher hematocrit levels might outweigh the risk of transfusion in high-risk patients. Therefore, this study aimed to evaluate the effects of perioperative hematocrit levels on mortality in patients requiring prolonged mechanical ventilation (PMV) after a cardiovascular surgery. This single-center retrospective cohort study was conducted on 172 patients who underwent cardiovascular surgery with cardiopulmonary bypass or off-pump coronary artery bypass grafting and required PMV for ≥72 hours in the intensive care unit (ICU) from 2008 to 2012 at the Yokohama City University Medical Center in Yokohama, Japan. Patients were classified according to hematocrit levels on ICU admission: high (≥30%) and low (<30%) groups. Of 172 patients, 86 were included to each of the low-hematocrit and high-hematocrit groups, with median hematocrit levels (first to third quartiles) of 27.4% (25.4%–28.7%) and 33.0% (31.3%–35.5%), respectively. The difference in survival rates was significant between the two groups using the log-rank test (HR 0.55, 95% CI 0.32 to 0.95, p=0.033). Cox regression analysis revealed that ≥30% increase in hematocrit levels on ICU admission was significantly associated with decreased long-term mortality (HR 0.40, 95% CI 0.20 to 0.80, p=0.0095). Lower hematocrit levels on ICU admission was a risk factor for increased long-term mortality, and higher hematocrit levels might outweigh the risk of transfusion in patients requiring PMV after a cardiovascular surgery.